EVA Vitrectomy Pack Gravity Input 23G 8300.23G01Recalls & reported problems
D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08717872018997), received between Mar 21, 2018 and Jun 13, 2018 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Material Separation” (3 reports).
1 other recall cover devices cleared under the same FDA submission (K190875); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Material Separation3
- Partial Blockage1
Patient problems
- No Consequences Or Impact To Patient3
- Intraocular Pressure, Delayed, Uncontrolled1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 13, 2018Material Separation; Material Separation
THE PROBE WAS SEPARATED AT THE BACK AFTER 5 SECONDS OF OPERATION. ALSO AIR COMING FROM THE PROBE TIP. NO SAMPLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7596791 ↗MalfunctionJun 13, 2018Material Separation; Material Separation
THE PROBE WAS SEPARATED AT THE BACK AFTER 5 SECONDS OF OPERATION. ALSO AIR COMING FROM THE PROBE TIP. NO SAMPLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7596785 ↗MalfunctionJun 13, 2018Material Separation; Material Separation
THE PROBE WAS SEPARATED AT THE BACK AFTER 5 SECONDS OF OPERATION. NO SAMPLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7596732 ↗InjuryMar 21, 2018Partial Blockage; Partial Blockage
A REPORT HAS BEEN RECEIVED OF AN INCIDENT THAT OCCURRED IN (B)(6) THE FOLLOWING WAS REPORTED: "WE RECEIVED AN OFFICIAL COMPLAINT CONCERNING A PROBLEM WITH THE INFUSION LINE. AT THE BEGINNING OF THE 23G VITRECTOMY, EYE WITHOUT TONE. BAD IRRIGATION. THE INFUSION LINE SHOW A DEFECT AT THE OUTPUT. EYE WITHOUT TONE - (SERIOUS RISK TO THE PATIENT).
Patient problems: Intraocular Pressure, Delayed, Uncontrolled
MAUDE report 7359528 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K190875. One submission often covers many models, so check the product and lot details in each record.
- Z-2252-2021 · May 21, 2019 · Open, ClassifiedThe device is a 25-gauge infusion line that is part of 25-gauge surgical pack labeled TDC Vitrectomy Pack VGPC 25g, Product Number 8525.201.
Other Unit, Phacofragmentation devices
- Centurion 8065751763Alcon Laboratories, Inc. · Unit, phacofragmentation728 reports
- Centurion 8065753057Alcon Laboratories, Inc. · Unit, phacofragmentation639 reports
- CENTURION® 8065752914Alcon Laboratories, Inc. · Unit, phacofragmentation571 reports
- Constellation, Ultravit, 25+, TotalPlus, EdgePlus 8065751617Alcon Laboratories, Inc. · Unit, phacofragmentation2 recalls398 reports
- Alcon 8065752201Alcon Laboratories, Inc. · Unit, phacofragmentation1 recall386 reports
- Alcon 8065752200Alcon Laboratories, Inc. · Unit, phacofragmentation1 recall366 reports
- Constellation, Ultravit, 25+, TotalPlus, EdgePlus 8065751767Alcon Laboratories, Inc. · Unit, phacofragmentation2 recalls302 reports
- Constellation, ULTRAVIT, Engauge, 25+ 8065752415Alcon Laboratories, Inc. · Unit, phacofragmentation369 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page